Ultrasound renal denervation is now guideline-recommended: how do I get started?

Sponsored by Recor Medical Europe

Anchorperson: A. Sharp

Spokesperson: F. L. Ribichini

Summary

Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and ESH now recommend this therapy for patients with uncontrolled hypertension; and learn how to implement a successful uRDN programme in your clinic. From patient selection and multidisciplinary teamwork to the practicalities of setting up your own RDN pathway, this session provides expert guidance and a clear view of what’s next for renal denervation.

Learning Objectives

To learn about the latest clinical data on renal denervation and how to apply it in clinical practice
To understand the new clinical guidelines in clinical practice with patient cases
To learn how to set up a renal denervation programme in your clinic
To get an outlook on the next steps and future for renal denervation